Suzuki Yasuyuki, Matsumoto Naoya, Sugai Shonosuke, Makita Ayano, Yumikura Tetsuro, Yoda Shunichi, Amano Yasuo, Okumura Yasuo
Department of Cardiology, Nihon University Hospital, Tokyo, Japan.
Department of Cardiology, Kawaguchi Municipal Medical Center, Saitama, Japan.
Ann Nucl Cardiol. 2022;8(1):113-116. doi: 10.17996/anc.22-00166. Epub 2022 Aug 31.
Since Agatston et al. first reported quantification of the coronary artery calcification score (CACS) in 1990, discussion of its clinical significance and use in diagnostic management has continued. Recent papers have reported the relationship between CACS and myocardial perfusion single photon emission computed tomography (SPECT: MPS) and its combined diagnostic value. When interpreting CACS results, it should be noted that the frequency of significant ischemia detected by MPS, likelihood of coronary artery disease (CAD), and event rate gradually increased from mild to moderate CACS (1-400). At present, high CACS is considered to be moderately consistent with abnormal MPS, and abnormal CACS in normal MPS may contribute to CAD risk stratification. However, it should be noted that CACS=0 does not completely exclude CAD, which is particularly important when using CACS as a gatekeeper for MPS. Both stand-alone computed tomography (CT) scanner and hybrid SPECT-CT scanner are available for combined risk stratification of CACS and MPS in addition to improvement of image quality with attenuation correction.
自1990年阿加斯顿等人首次报告冠状动脉钙化评分(CACS)的量化以来,关于其临床意义及在诊断管理中的应用的讨论一直在持续。近期论文报道了CACS与心肌灌注单光子发射计算机断层扫描(SPECT:MPS)之间的关系及其联合诊断价值。在解读CACS结果时,应注意MPS检测到的显著缺血频率、冠状动脉疾病(CAD)的可能性以及事件发生率从轻度到中度CACS(1 - 400)逐渐增加。目前,高CACS被认为与MPS异常中度一致,正常MPS中的异常CACS可能有助于CAD风险分层。然而,应注意CACS = 0并不能完全排除CAD,这在将CACS用作MPS的把关指标时尤为重要。除了通过衰减校正提高图像质量外,独立计算机断层扫描(CT)扫描仪和混合SPECT - CT扫描仪均可用于CACS和MPS的联合风险分层。